Constellation Pharmaceuticals (CNST) – Corporate News
-
Constellation Pharmaceuticals (CNST) Provides Update from the Ongoing MANIFEST Study of Pelabresib
-
Royalty Pharma plc (RPRX) Announces $2.025 Billion Strategic Funding from MorphoSys AG (MOR)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CNST Stock Lookup